The Senior Financial Analyst – MiniMed Americas Controllership (U.S. & Canada) supports day-to-day accounting and financial reporting activities for the MiniMed commercial and operational entities across the United States and Canada. This role is responsible for period-end close under US GAAP, balance sheet integrity, internal controls, and audit coordination, with a focus on Americas legal entities and regional operations. The role also supports Day-1 readiness and post-Day-1 stabilization for the Record-to-Report workstream as part of the Diabetes division separation effort. This position is an exciting opportunity to work with Medtronic's Diabetes business. Medtronic has announced its intention to separate the Diabetes division to promote future growth and innovation within the business and reallocate investments and resources across Medtronic, subject to applicable information and consultation requirements. This separation provides our team with a bold opportunity to unleash our potential, enabling us to operate with greater speed and agility. As a separate entity, we anticipate leveraging increased investments to drive meaningful innovation and enhance our impact on patient care. As a Senior Financial Analyst, you will be a key contributor within the Americas controllership team, supporting statutory and US GAAP accounting, period-end close, and internal controls for U.S. and Canadian MiniMed entities. You will partner closely with Corporate Consolidations, FP&A, Tax, Technical Accounting, and external auditors to ensure accurate, timely, and compliant financial reporting during and after the separation.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
5,001-10,000 employees